MedPath

Viatris Healthcare Hong Kong Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

189

PPB:189

Drug Approvals

RITONAVIR TABLETS USP 100MG

Approval Date
Feb 5, 2025
PPB

ERLOTINIB TABLETS 150MG

Approval Date
Sep 24, 2024
PPB

ERLOTINIB TABLETS 100MG

Approval Date
Sep 24, 2024
PPB

YUPELRI INHALATION SOLUTION 175MCG/3ML

Approval Date
Dec 19, 2023
PPB

METFORMIN HCL TABLETS 500MG

Approval Date
Oct 11, 2023
PPB

DIAGEN MR MODIFIED RELEASE TABLETS 60MG

Approval Date
Nov 23, 2022
PPB

NITROSTAT TABLETS 0.6MG

Approval Date
Nov 23, 2021
PPB

IMATINIB MYLAN TABLETS 100MG

Approval Date
Jul 26, 2021
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.